| Literature DB >> 27143783 |
Patrizio Lancellotti1, Philippe Pibarot2, John Chambers3, Thor Edvardsen4, Victoria Delgado5, Raluca Dulgheru6, Mauro Pepi7, Bernard Cosyns8, Mark R Dweck9, Madalina Garbi10, Julien Magne11, Koen Nieman12, Raphael Rosenhek13, Anne Bernard14, Jorge Lowenstein15, Marcelo Luiz Campos Vieira16, Arnaldo Rabischoffsky17, Rodrigo Hernández Vyhmeister18, Xiao Zhou19, Yun Zhang20, Jose-Luis Zamorano21, Gilbert Habib22.
Abstract
Prosthetic heart valve (PHV) dysfunction is rare but potentially life-threatening. Although often challenging, establishing the exact cause of PHV dysfunction is essential to determine the appropriate treatment strategy. In clinical practice, a comprehensive approach that integrates several parameters of valve morphology and function assessed with 2D/3D transthoracic and transoesophageal echocardiography is a key to appropriately detect and quantitate PHV dysfunction. Cinefluoroscopy, multidetector computed tomography, cardiac magnetic resonance imaging, and to a lesser extent, nuclear imaging are complementary tools for the diagnosis and management of PHV complications. The present document provides recommendations for the use of multimodality imaging in the assessment of PHVs. Published on behalf of the European Society of Cardiology. All rights reserved.Entities:
Keywords: cardiac magnetic resonance; cinefluoroscopy; computed tomography; echocardiography; nuclear imaging; prosthetic heart valve
Mesh:
Year: 2016 PMID: 27143783 DOI: 10.1093/ehjci/jew025
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875